From Yahoo Finance: 2025-05-31 11:00:00 Former Conservative cabinet minister Nadhim Zahawi has withdrawn from the “British bid” for The Telegraph,
From Barchart: 2025-05-31 10:38:00 Chinese AI company DeepSeek has unveiled a major upgrade to its large language model, R1, in
From Yahoo Finance: 2025-05-31 10:30:00 Connie Morton’s husband passed away due to complications from Parkinson’s disease after 18 years of
From Nasdaq: 2025-05-31 09:55:00 Regeneron Pharmaceuticals Inc. announced positive results from the Phase 3 C-POST trial, showing that PD-1 inhibitor
From Nasdaq: 2025-05-31 09:36:00 Genentech, a member of the Roche Group, reported positive final results from the Phase III INAVO120
From Yahoo Finance: 2025-05-31 09:33:00 Former labor secretary Robert Reich highlighted the drastic gap between CEO pay, which has surged
From Barchart: 2025-05-31 09:00:00 Larry Ellison, co-founder of Oracle, and Bill Gates, former CEO of Microsoft, engaged in a fierce
From Yahoo Finance: 2025-05-31 08:46:00 Herc Holdings (HRI) and H&E Equipment Services, Inc. d/b/a H&E Rentals (HEES) have announced the
From Yahoo Finance: 2025-05-31 08:40:00 TD Cowen has raised the price target for L3Harris Technologies to $270 from $240. This
From Yahoo Finance: 2025-05-31 08:35:00 Wedbush lowers Best Buy’s price target to $70 from $75, maintaining a Neutral rating. The
From Nasdaq: 2025-05-31 08:15:00 The Trade Desk (NASDAQ: TTD) faces a stock decline of 47% from its 52-week high, but
From GlobeNewswire: 2025-05-31 08:05:00 Roche’s ItovebiTM (inavolisib)-based regimen has shown a 30% reduced risk of death in people with PIK3CA-mutated
From Yahoo Finance: 2025-05-31 08:04:00 Crown Castle Inc. (NYSE:CCI) owns and operates cell towers and fiber solutions across the U.S.
From GlobeNewswire: 2025-05-31 08:00:00 The Phase III NAPOLI 3 trial reveals a median overall survival of 19.5 months among long-term
From GlobeNewswire: 2025-05-31 08:00:00 The Phase 1b trial follow-up on IMA203 PRAME cell therapy in metastatic melanoma patients shows promising
From GlobeNewswire: 2025-05-31 08:00:00 Xilio Therapeutics announced preliminary results from a Phase 2 clinical trial showing a 26% objective response
From GlobeNewswire: 2025-05-31 08:00:00 Results from the Phase 3 VERITAC-2 clinical trial show vepdegestrant improved progression-free survival by 2.9 months
From Barchart: 2025-05-31 08:00:00 Super Micro Computer Inc recently unveiled new data center solutions in mid-May. The company is hopeful
From Nasdaq: 2025-05-31 07:34:00 Validea’s ETF fundamental report for SPDR Health Care Select Sector SPDR Fund (XLV) examines its exposure
From Yahoo Finance: 2025-05-31 07:15:00 Three high-yield stocks under $100 to consider are United Parcel Service (UPS), Brookfield Renewable Partners
From Nasdaq: 2025-05-31 06:55:00 Dollar-cost averaging is a strategy where investors make routine investments over time, even when stock prices
From Yahoo Finance: 2025-05-31 06:20:00 AAVE rebounds from 15% drop, climbs above $250 amid growing DeFi momentum. Global trade tensions
From Nasdaq: 2025-05-31 05:55:00 The Social Security Administration is set to announce the 2026 cost-of-living adjustment (COLA) in mid-October, sparking
From Nasdaq, Inc.: 2025-05-31 05:53:00 Today’s upgrades for Validea’s Book/Market Investor model are based on Joseph Piotroski’s strategy. AUO CORP
From Nasdaq: 2025-05-31 04:45:00 SoundHound AI (NASDAQ: SOUN) saw a tremendous 836% gain in 2024, but has since dropped 46%